Back
JBG SMITH Properties 10K Form
Sell
38
JBGS
JBG SMITH Properties
Last Price:
16.90
Seasonality Move:
9.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-04 | 10Q | JBGS/JBG SMITH Properties Quarterly |
2020-05-05 | 10Q | JBGS/JBG SMITH Properties Quarterly |
2020-02-25 | 10K | JBGS/JBG SMITH Properties Annual |
2019-11-05 | 10Q | JBGS/JBG SMITH Properties Quarterly |
2019-08-06 | 10Q | JBGS/JBG SMITH Properties Quarterly |
2019-05-07 | 10Q | JBGS/JBG SMITH Properties Quarterly |
Receive JBGS News And Ratings
See the #1 stock for the next 7 days that we like better than JBGS
JBGS Financial Statistics
Sales & Book Value
Annual Sales: | $604.2M |
---|---|
Cash Flow: | $-32.24M |
Price / Cash Flow: | 0 |
Annual Sales: | $22.29 |
Price / Book: | 0.76 |
Profitability
EPS (TTM): | -1.30000 |
---|---|
Net Income (TTM): | $-116.23M |
Gross Margin: | $313.53M |
Return on Equity: | -4.48% |
Return on Assets: | -2.15% |
JBG SMITH Properties Earnings Forecast
Key JBG SMITH Properties Financial Ratios
- The Gross Profit Margin over the past 11 years for JBGS is 51.89%.
- The Selling, General & Administrative Expenses for JBGS have been equal to 9.17% of Gross Profit Margin.
- The Interest Expense is -113.86% of Operating Income.
- The Net Earning history of JBGS is -13.24% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 4 years.
JBG SMITH Properties Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Office REITs |
Sector: | Real Estate |
Current Symbol: | JBGS |
CUSIP: | 46590V |
Website: | jbgsmith.com |
Debt
Debt-to-Equity Ratio: | 1.39 |
---|---|
Current Ratio: | 2.16 |
Quick Ratio: | 1.86 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
JBGS Technical Analysis vs Fundamental Analysis
Sell
38
JBG SMITH Properties (JBGS)
is a Sell
Is JBG SMITH Properties a Buy or a Sell?
-
JBG SMITH Properties stock is rated a Sell
The current JBG SMITH Properties [JBGS] share price is $16.90. The Score for JBGS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.